Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06563778
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-19
Brief Title:
ChidamideDecitabine Plus Anti-PD-1 Antibody for Patients With RR cHL Who Are Transplant-ineligible or Refused Transplant
Sponsor:
Organization:
None